188 related articles for article (PubMed ID: 37806193)
1. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
[TBL] [Abstract][Full Text] [Related]
2. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
[TBL] [Abstract][Full Text] [Related]
3. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
[TBL] [Abstract][Full Text] [Related]
4. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
[TBL] [Abstract][Full Text] [Related]
5. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.
Thomassin-Naggara I; Poncelet E; Jalaguier-Coudray A; Guerra A; Fournier LS; Stojanovic S; Millet I; Bharwani N; Juhan V; Cunha TM; Masselli G; Balleyguier C; Malhaire C; Perrot NF; Sadowski EA; Bazot M; Taourel P; Porcher R; Darai E; Reinhold C; Rockall AG
JAMA Netw Open; 2020 Jan; 3(1):e1919896. PubMed ID: 31977064
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
[TBL] [Abstract][Full Text] [Related]
7. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
[TBL] [Abstract][Full Text] [Related]
8. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
[TBL] [Abstract][Full Text] [Related]
9. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
10. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.
Thomassin-Naggara I; Belghitti M; Milon A; Abdel Wahab C; Sadowski E; Rockall AG;
Eur Radiol; 2021 Dec; 31(12):9588-9599. PubMed ID: 34041567
[TBL] [Abstract][Full Text] [Related]
11. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
Zhang Q; Dai X; Li W
AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
[No Abstract] [Full Text] [Related]
13. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group.
Woo S; Andrieu PC; Abu-Rustum NR; Broach V; Zivanovic O; Sonoda Y; Chi DS; Aviki E; Ellis A; Carayon P; Hricak H; Vargas HA
Acad Radiol; 2024 Apr; 31(4):1388-1397. PubMed ID: 37661555
[TBL] [Abstract][Full Text] [Related]
14. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
Shi Y; Li H; Wu X; Li X; Yang M
J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
[TBL] [Abstract][Full Text] [Related]
15. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
Dabi Y; Rockall A; Razakamanantsoa L; Guerra A; Fournier LS; Fotopoulou C; Touboul C; Thomassin-Naggara I;
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():135-142. PubMed ID: 38237312
[TBL] [Abstract][Full Text] [Related]
16. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
[TBL] [Abstract][Full Text] [Related]
17. O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.
Thomassin-Naggara I; Dabi Y; Florin M; Saltel-Fulero A; Manganaro L; Bazot M; Razakamanantsoa L
J Magn Reson Imaging; 2024 Mar; 59(3):720-736. PubMed ID: 37550825
[TBL] [Abstract][Full Text] [Related]
18. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
20. Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI.
Suarez-Weiss KE; Sadowski EA; Zhang M; Burk KS; Tran VT; Shinagare AB
Radiographics; 2023 Jul; 43(7):e220142. PubMed ID: 37319025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
